MA45601A - Systèmes et procédés de détermination de la sensibilité à l'insuline - Google Patents

Systèmes et procédés de détermination de la sensibilité à l'insuline

Info

Publication number
MA45601A
MA45601A MA045601A MA45601A MA45601A MA 45601 A MA45601 A MA 45601A MA 045601 A MA045601 A MA 045601A MA 45601 A MA45601 A MA 45601A MA 45601 A MA45601 A MA 45601A
Authority
MA
Morocco
Prior art keywords
insulin
systems
methods
determining susceptibility
susceptibility
Prior art date
Application number
MA045601A
Other languages
English (en)
Inventor
Tinna Björk Aradóttir
Henrik Bengtsson
Pete Brockmeier
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MA45601A publication Critical patent/MA45601A/fr

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/40—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
MA045601A 2016-07-08 2017-06-22 Systèmes et procédés de détermination de la sensibilité à l'insuline MA45601A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16178558 2016-07-08

Publications (1)

Publication Number Publication Date
MA45601A true MA45601A (fr) 2019-05-15

Family

ID=56409486

Family Applications (2)

Application Number Title Priority Date Filing Date
MA045601A MA45601A (fr) 2016-07-08 2017-06-22 Systèmes et procédés de détermination de la sensibilité à l'insuline
MA045579A MA45579A (fr) 2016-07-08 2017-06-22 Systèmes et procédés de détermination de la sensibilité à l'insuline

Family Applications After (1)

Application Number Title Priority Date Filing Date
MA045579A MA45579A (fr) 2016-07-08 2017-06-22 Systèmes et procédés de détermination de la sensibilité à l'insuline

Country Status (6)

Country Link
US (2) US11195606B2 (fr)
EP (2) EP3482314B1 (fr)
JP (4) JP7042791B2 (fr)
CN (2) CN109661706B (fr)
MA (2) MA45601A (fr)
WO (2) WO2018007160A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA45601A (fr) 2016-07-08 2019-05-15 Novo Nordisk As Systèmes et procédés de détermination de la sensibilité à l'insuline
FR3081316B1 (fr) 2018-05-22 2022-12-09 Commissariat Energie Atomique Systeme automatise de controle de la glycemie d'un patient
US11154223B2 (en) 2019-08-30 2021-10-26 TT1 Products, Inc. Biomarker monitoring fitness system
WO2021108431A1 (fr) * 2019-11-25 2021-06-03 Abbott Diabetes Care Inc. Procédés, dispositifs et systèmes d'analyse de paramètres physiologiques
US20210228804A1 (en) * 2020-01-23 2021-07-29 Insulet Corporation Meal insulin determination for improved post prandial response
EP4165649A2 (fr) * 2020-06-10 2023-04-19 Bigfoot Biomedical, Inc. Système de traitement du diabète en boucle fermée détectant un repas ou un bolus manqué
US11284818B2 (en) * 2020-08-31 2022-03-29 TT1 Products, Inc. Glucose exposure diagnostics and therapeutics related thereto
USD1004777S1 (en) 2021-09-01 2023-11-14 TT1 Products, Inc. Wrist reader
CN114145738B (zh) * 2022-02-10 2022-06-24 苏州百孝医疗科技有限公司 分析物浓度数据生成方法和装置、监测分析物水平的系统
US20230330336A1 (en) * 2022-04-18 2023-10-19 Luna Health, Inc. Systems, devices and related methods of coordinating insulin management and delivery modes in fasting & non-fasting periods
CN119215262B (zh) * 2023-06-30 2026-02-06 武汉联影智融医疗科技有限公司 针对胰岛素基础率的自动调整方法、装置和第一设备
FR3162133A1 (fr) * 2024-05-16 2025-11-21 Diabeloop Systèmes et procédés de régulation de la glycémie en boucle fermée

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656114B1 (en) * 1998-11-30 2003-12-02 Novo Noadisk A/S Method and a system for assisting a user in a medical self treatment, said self treatment comprising a plurality of actions
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
US6883521B2 (en) 2001-08-24 2005-04-26 Dimensional Dosing Systems, Inc. Method and apparatus for dosing single and multi-agent therapy
US6691043B2 (en) 2001-08-28 2004-02-10 Maxi-Med, Llc Bolus calculator
US7404796B2 (en) 2004-03-01 2008-07-29 Becton Dickinson And Company System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
EP1711791B1 (fr) 2003-12-09 2014-10-15 DexCom, Inc. Traitement de signal pour capteur continu d'analyte
JP4273036B2 (ja) * 2004-05-12 2009-06-03 中 奥村 投薬支援プログラム、投薬支援装置、投薬支援プログラムを記録した記録媒体及び投薬支援システム
US20090036753A1 (en) 2007-07-31 2009-02-05 King Allen B Continuous glucose monitoring-directed adjustments in basal insulin rate and insulin bolus dosing formulas
US20100262434A1 (en) 2007-12-13 2010-10-14 Shaya Steven A Method and apparatus to calculate diabetic sensitivity factors affecting blood glucose
US10624577B2 (en) 2008-04-04 2020-04-21 Hygieia, Inc. Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus
US9220456B2 (en) * 2008-04-04 2015-12-29 Hygieia, Inc. Systems, methods and devices for achieving glycemic balance
DK2260423T3 (en) 2008-04-04 2018-06-06 Hygieia Inc DEVICE FOR OPTIMIZING A PATIENT'S INSULIN DOSAGE PLAN
US8597570B2 (en) * 2008-11-04 2013-12-03 Panasonic Corporation Measurement device, insulin infusion device, measurement method, method for controlling insulin infusion device, and program
WO2010072387A2 (fr) * 2008-12-23 2010-07-01 Roche Diagnostics Gmbh Procédé de gestion et système pour la mise en oeuvre, l'exécution, le recueil de données et l'analyse de données d'une procédure de recueil structurée qui fonctionne sur un dispositif de recueil
US20110098548A1 (en) * 2009-10-22 2011-04-28 Abbott Diabetes Care Inc. Methods for modeling insulin therapy requirements
WO2012122520A1 (fr) 2011-03-10 2012-09-13 Abbott Diabetes Care Inc. Dispositif de surveillance de substance à analyser à fonctions multiples et procédés d'utilisation
TW201333870A (zh) * 2011-12-21 2013-08-16 艾登工具股份有限公司 決定病人胰島素療法的系統及方法
US10391242B2 (en) * 2012-06-07 2019-08-27 Medtronic Minimed, Inc. Diabetes therapy management system for recommending bolus calculator adjustments
AU2015100005A4 (en) 2014-01-27 2015-02-12 Digital Medics Pty. Ltd. Diabetic Connect Bluetooth Adaptor
US10456090B2 (en) 2014-11-22 2019-10-29 Bigfoot Biomedical, Inc. Method to determine individualized insulin sensitivity and optimal insulin dose by linear regression, and related systems
MA45601A (fr) 2016-07-08 2019-05-15 Novo Nordisk As Systèmes et procédés de détermination de la sensibilité à l'insuline

Also Published As

Publication number Publication date
EP3482314B1 (fr) 2020-11-18
MA45579A (fr) 2019-05-15
US20190228853A1 (en) 2019-07-25
JP2022043112A (ja) 2022-03-15
WO2018007160A1 (fr) 2018-01-11
JP7042791B2 (ja) 2022-03-28
JP7217698B2 (ja) 2023-02-03
EP3482314A1 (fr) 2019-05-15
EP3482319A1 (fr) 2019-05-15
CN109690685B (zh) 2023-09-08
EP3482319B1 (fr) 2020-12-09
JP2022043110A (ja) 2022-03-15
CN109690685A (zh) 2019-04-26
US20190348164A1 (en) 2019-11-14
US11195606B2 (en) 2021-12-07
US11521730B2 (en) 2022-12-06
CN109661706B (zh) 2023-06-27
WO2018007161A1 (fr) 2018-01-11
JP2019530915A (ja) 2019-10-24
JP2019530914A (ja) 2019-10-24
CN109661706A (zh) 2019-04-19

Similar Documents

Publication Publication Date Title
MA45579A (fr) Systèmes et procédés de détermination de la sensibilité à l'insuline
EP3545466A4 (fr) Systèmes et procédés de détection d'objets dans des images
EP3466031A4 (fr) Systèmes et procédés de détection d'anomalie
EP3529780A4 (fr) Systèmes et procédés d'affichage d'images représentatives
EP3513265A4 (fr) Systèmes et procédés de détermination de quasi-collision
EP2981623A4 (fr) Systèmes et procédés d'évaluation de microbiomes et de traitement de ceux-ci
EP3350979A4 (fr) Systèmes et procédés destinés à la détection et l'évaluation des conducteurs distraits
EP3491820A4 (fr) Procédés et systèmes de surveillance d'objet
EP3469524A4 (fr) Procédés et systèmes de calculs quantiques
EP3512420A4 (fr) Systèmes et procédés d'imagerie améliorés
EP3371572A4 (fr) Systèmes et procédés d'imagerie optogénétique
EP3485237A4 (fr) Systèmes et procédés de mesure de dose
EP3542289A4 (fr) Systèmes et procédés d'imagerie en temps réel
EP3481674A4 (fr) Systèmes et procédés de détermination d'accident
EP3350578A4 (fr) Systèmes et procédés d'imagerie couleur
EP3285635A4 (fr) Systèmes et procédés de détermination de distance par rapport à un objet
EP2997531A4 (fr) Procédés et systèmes de fourniture d'identifiants de paiement
EP3443749A4 (fr) Systèmes et procédés d'affichage et de traitement de vidéo
EP3509494A4 (fr) Systèmes et procédés de détection d'infiltration iv
EP3402384A4 (fr) Systèmes et procédés de détermination de la distance par rapport à un objet
EP2916721A4 (fr) Systèmes et procédés d'évaluation de neuropathologies
EP2806781A4 (fr) Systèmes et procédés d'imagerie
EP3542299A4 (fr) Systèmes et procédés de sécurisation d'accès à des ressources
EP3420456A4 (fr) Systèmes et procédés anti-répétitions
EP3329456A4 (fr) Procédés et systèmes de détermination de viabilité économique d'un microréseau